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Neuropathic Sensitization of Behavioral Reflexes
and Spinal NMDA Receptor/CaM Kinase II
Interactions Are Disrupted in PSD-95 Mutant Mice
Results
PSD-95 Expression in Spinal Cord
Using histochemical staining for the -galactosidase re-
porter gene, we showed that PSD-95 expression is spe-
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cifically restricted to lamina II of the spinal dorsal horn, aR(D)SVS
prime location for the processing of nociceptive afferentUniversity of Edinburgh
inputs (Figure 1A), and is found throughout lumbar andSummerhall, Edinburgh EH9 1QH
thoracic spinal cord (Figure 1B). This distribution over-United Kingdom
laps with those of NMDA receptor subunits (particularly2 Division of Neuroscience
NR2B) throughout lumbar and thoracic spinal cord [2].University of Edinburgh
PSD-95 expression was not detected in dorsal root entry1 George Square
zones (Figure 1B, arrow), dorsal root ganglion (DRG),Edinburgh EH8 9JZ
dorsal roots, or sciatic nerve (data not shown). UsingUnited Kingdom
coimmunoprecipitation, we could isolate NMDA recep-3 MRC Membrane and Adapter Proteins
tor complexes from spinal cord that contained NR1,Co-operative Group and Membrane Biology Group
NR2A, NR2B, and PSD-95, similar to those found inDivision of Biomedical and Clinical Laboratory
forebrain [3, 4] (Figure 1C).Sciences
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Edinburgh EH8 9XD PSD-95 Mutant Mice Lack Behavioral Reflex
United Kingdom Sensitization Following CCI
We used the CCI model of neuropathic pain to examine
the effects of sciatic nerve injury in homozygous PSD-
95 mutant mice and their wild-type littermates. Over
Summary 7–10 days following CCI (under halothane anesthesia),
wild-type mice progressively developed marked ipsilat-
Chronic pain due to nerve injury is resistant to current eral thermal hyperalgesia (reduced paw withdrawal la-
analgesics. Animal models of neuropathic pain show tency, PWL; Figure 2A), mechanical allodynia (reduced
neuronal plasticity and behavioral reflex sensitization paw withdrawal threshold, PWT; Figure 2C), and cold
in the spinal cord that depend on the NMDA receptor allodynia (increased suspended paw elevation time,
[1, 2]. We reveal complexes of NMDA receptors with SPET; Figure 2E). All responses from the contralateral
the multivalent adaptor protein PSD-95 [3, 4] in the hind limb remained unaltered. Thermal hyperalgesia and
dorsal horn of spinal cord and show that PSD-95 plays mechanical allodynia were absent in PSD-95 mutant
a key role in neuropathic reflex sensitization. Using mice (Figures 2B and 2D), while cold allodynia was se-
mutant mice expressing a truncated form of the PSD- verely attenuated, reaching statistical significance at
95 molecule [5], we show their failure to develop the only one time point (Figure 2F). No differences in motor
NMDA receptor-dependent hyperalgesia and allodynia function or coordination (as measured by the rotarod
seen in the CCI model of neuropathic pain [6], but test) were observed in PSD-95 mutants compared to
normal inflammatory nociceptive behavior following wild-type mice. In addition, there was no evidence for
the injection of formalin. In wild-type mice following anatomical alterations in afferents of the mutant mice,
CCI, CaM kinase II inhibitors attenuate sensitization with similar axon diameter and myelin thickness profiles
of behavioral reflexes, elevated constitutive (autopho- for A, A, and C fibers between naive wild-type and
sphorylated) activity of CaM kinase II is detected in homozygous PSD-95 mutant mice (in accordance with
spinal cord, and increased amounts of phospho-Thr286 previous findings [7, 8]), and the extent of CCI-induced
CaM kinase II coimmunoprecipitate with NMDA recep- changes in afferent fibers was unaltered.
tor NR2A/B subunits. Each of these changes is pre-
vented in PSD-95 mutant mice although CaM kinase PSD-95 Mutant Mice Display Normal Responses
II is present and can be activated. Disruption of CaM to Inflammatory Nociceptive Stimuli
kinase II docking to the NMDA receptor and activation Sensitization of nociceptive reflexes can also be brought
may be responsible for the lack of neuropathic behav- about by peripheral inflammatory stimuli [9], but inflam-
ioral reflex sensitization in PSD-95 mutant mice. matory and neuropathic states display a number of dis-
tinct characteristics [1, 10]. We therefore tested whether
PSD-95 mutant mice also display a deficit in behavioral
*Correspondence: s.m.fleetwood-walker@ed.ac.uk responses to inflammation by intraplantar injection of
4 Present address: Department of Anatomy and Developmental Biol- formalin (10 l of 1.5% solution in saline, during brief
ogy, Medawar Building, University College London, Gower St., Lon-
halothane anesthesia [11, 12]). PSD-95 mutant mice anddon WC1E 6BT, United Kingdom.
wild-type littermates displayed the same responses of5 Present address: Cell Factors plc, St. John’s Innovation Centre,
Cowley Road, Cambridge CB4 0WS, United Kingdom. paw licking and flicking in the early acute phase of the
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Figure 1. Expression of PSD-95 and Components of the NMDA Receptor Complex in Spinal Cord
Heterozygous PSD-95 (wt/mutant) animals (n  5) were perfused with 4% paraformaldehyde in 0.1 M phosphate buffer. 10 m sections were
washed with ice-cold PBS/MgCl2 and then 0.041% MgCl2, 0.01% Na deoxycholate, 0.02% Nonidet-NP40, in 0.1 M PBS. Sections were stained
at 22C in 0.042% potassium ferrocyanide, 0.033% potassium ferricyanide in detergent buffer with 1 g/ml 5-bromo-4-chloro-3-indolyl--D-
galactoside, and incubated at 37C in the dark for 4–6 hr.
(A) Transverse section, showing specific distribution of -galactosidase-positive cells in lamina II (outlined with dashed line) of the superficial
dorsal horn.
(B) Longitudinal section showing staining in dorsal horn, but not at the site of dorsal root entry (arrow). Scale bar equals 10 m.
(C) Immunoblots for the presence of NMDA receptor complex proteins in NR2A/B-directed immunoprecipitates of L3-L6 spinal cord from
wild-type mice.
formalin test (5–10 min following injection), and the late PSD-95 mutant mice following CCI were unaffected by
intrathecal administration of (R)-CPP, with PWL and(inflammatory) phase of the response (25 min to 1 hr)
was also indistinguishable between the mutant and wild- PWT values (which, as described, displayed no sensiti-
zation in these animals) remaining at 98.4% 7.2% andtype mice (Figure 2G), in striking contrast to the lack of
neuropathic behavioral reflex sensitization seen in the 94.5%  4.9% of predrug controls. Correspondingly,
naive PSD-95 mutants showed no changes in PWL andmutants. The degree of peripheral inflammation as as-
sessed by paw volume was the same for PSD-95 mutant PWT following intrathecal injection of NMDA, with values
remaining at 96.4%  5.0% and 99.4%  6.3% of pre-and wild-type mice.
drug controls. These findings suggest that NMDA recep-
tor:PSD-95 interactions in spinal cord play a key role inNMDA Receptor-Dependent Hyperalgesia
and Allodynia in Wild-Type, but not the development of neuropathic behavioral reflex sensi-
tization. In both wild-type mice and PSD-95 mutantPSD-95 Mutant Mice
Intrathecal administration of the selective NMDA recep- mice, the second (inflammatory) phase of the nocicep-
tive reflex response to formalin was completely inhibitedtor antagonist (R)-CPP (under brief halothane anesthe-
sia) completely reversed thermal hyperalgesia and me- by intrathecal injection of 100 pmol (R)-CPP. The mean
number of paw flinches/flicks over the peak 15 min ofchanical allodynia that had developed ipsilateral to CCI
in wild-type mice, with no detectable effect on contralat- the second phase formalin response was reduced by
(R)-CPP to 11.5%  4.3% of control in wild-type anderal responses or in naive animals. At 10–30 min follow-
ing injection of (R)-CPP (100 pmole), the ipsilateral: by 10.1%  5.2% in PSD-95 mutants (n  4; p  0.05
by Student’s t test). Intrathecal injection of saline hadcontralateral differences in PWL and PWT (thermal hy-
peralgesia and mechanical allodynia) were reduced to no detectable effect on formalin responses with corre-
sponding values remaining within 6% of those from un-11.6%  5.9% and 8.3%  3.5% of predrug differences
(n 6, p 0.05 by Wilcoxon test in each case). Recovery injured controls. This indicates that while this inflamma-
tory nociceptive behavioral response involves the NMDAwas complete by 60–80 min. The equivalent values for
saline were 94.8%  3.9% and 90.0%  5.3%, respec- receptor, it does not share the additional requirement
for intact PSD-95 that is seen in the behavioral reflextively. The behavioral changes brought about following
CCI were bilaterally mimicked in naive wild-type mice sensitization induced by CCI.
by intrathecal administration of NMDA (250 pmole),
showing a 45.9%  5.1% reduction in mechanical paw CaM Kinase II Inhibitors Alleviate
Neuropathic Sensitizationwithdrawal threshold (PWT) and a 36.2% 3.9% reduc-
tion in thermal paw withdrawal latency (PWL) over 10–30 NMDA receptor:PSD-95 complexes in the forebrain in-
corporate the Ca2-dependent protein kinase, CaM ki-min following injection (p  0.05 in each case by Mann-
Whitney U test). In contrast, behavioral responses of nase II, docked to NR2 subunits [3, 4, 13–15], where it
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Figure 2. Behavioral Analysis of Wild-Type and PSD-95 Mutant Mice with Chronic Constriction Injury (CCI) to the Sciatic Nerve
Data show mean  SEM responses for each day before and following the induction of CCI. A variation of the chronic constriction injury (CCI)
model for rat [6] was used, whereby (under halothane anesthesia) three ligatures separated by 1 mm were tied loosely to constrict the tibial
branch of the sciatic nerve.
(A and B) In wild-type mice (A), paw withdrawal latency (PWL) from a noxious thermal stimulus (Hargreaves’ thermal stimulator) ipsilateral to
CCI (open circle) showed significant differences between postoperative and preoperative values (dagger indicates p  0.05; Kruskal-Wallis
one-way ANOVA) and from postoperative, contralateral (closed square) values (asterisk indicates p  0.05 by Student’s t test). No thermal
hyperalgesia was seen on the contralateral side (closed square) of wild-type mice (A) or in PSD-95 mutant mice (B) on either side.
(C and D) Paw withdrawal thresholds (PWT) from mechanical stimulation (von Frey filaments) for wild-type mice showed significant differences
between postoperative and preoperative values on the side ipsilateral (open circle) to CCI (dagger indicates p  0.05; Dunn’s Method ANOVA
on ranks) and between postoperative ipsilateral and contralateral values (asterisk indicates p  0.05, Mann-Whitney U test). No significant
differences were seen on the contralateral side (closed square) of wild-type mice (C) following nerve ligation or in PSD-95 mutants (D).
(E and F) The suspended paw elevation time (SPET) in response to a cold water (4C) stimulus is shown for the ipsilateral paw (open circle)
and contralateral paw (closed square) in wild-type mice (E) and in PSD-95 mutant mice (F). Following nerve ligation, SPET scores for the
contralateral paw were always zero for both wild-type and mutant mice. Statistically significant differences between postsurgery and presurgery
ipsilateral values are indicated by a dagger (p  0.05, Dunn’s Method ANOVA on ranks), and an asterisk (p  0.05, Mann-Whitney U test)
indicates statistically significant differences between postsurgery ipsilateral and contralateral responses.
(G) Data represent the number of paw flinch/flick responses per minute following the intraplantar injection of formalin. There was no significant
difference between responses of wild-type (closed diamond) and PSD-95 mutant (open diamond) mice in either the initial stage or the second
(inflammatory) stage of this test. n  5–9 in each case.
is predicted to play a particular role in NMDA receptor- the active kinase to the C-terminal domain of NR2B [17].
We first investigated whether CaM kinase II is necessarymediated synaptic plasticity [16]. Recent studies indi-
cate that Ca2/calmodulin stimulation induces auto- for the NMDA receptor-dependent sensitization of spi-
nal neurons in CCI. Intrathecal administration of the se-phosphorylation at Thr286 CaM kinase II and docking of
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Table 1. Effects of Acute Topical Drug Administration and of CCI on CaM Kinase II Activation in Spinal Cord of Wild-Type and
PSD-95 Mutant Mice
Topical Application to Spinal Dorsal Constitutive CaM Kinase II Activity (% of Maximal Activity Evoked In Vitro
Horn by Ca2/Calmodulin)
Wild-Type PSD-95 mutant
In Naive Mice
Saline 16.7  3.1 13.9  2.7
NMDA/glycine (150 nmole/30 nmole) 39.4  3.4* 37.0  4.1*
Ionomycin (5 nmole) 43.9  2.7* 44.8  5.2*
In Mice with Established CCI CCI Ipsi CCI Contra CCI Ipsi CCI Contra
Saline 28.8  3.1* 16.8  2.0 16.1  2.1 14.9  1.7
(R)-CPP (5 nmole) 14.3  1.5 17.5  3.0 - -
Agents were topically applied in a volume of 500 l for 15 min to the dorsal surface of L3-L6 spinal cord before rapid removal of tissue and
homogenization prior to CaM kinase II immunoprecipitation and kinase activity assay. The concentrations of NMDA/glycine and ionomycin
used were selected to provide maximal intensity stimuli and ensure detectability of changes in enzyme activity within the heterogeneous
tissue samples taken. The mean maximal CaM kinase II activity in immunoprecipitates from naive PSD-95 mutant mice spinal cord (stimulated
by Ca2/calmodulin addition in vitro) was unaltered from that in wild-type mice (108.3  13.7 and 97.8  13.1 pmoles 33P/min/g original
extract protein, respectively). Data are expressed as the percentage of maximal CaM kinase II activity (means  SEM, n  8–10). Statistically
significant differences are indicated by asterisk (p  0.05 by Mann Whitney U test, compared to corresponding saline values in naive mice
and by Wilcoxon test compared to corresponding contralateral values in mice with established CCI).
lective CaM kinase II inhibitors, KN-93 (120 pmole [18]) vitro by Ca2/calmodulin addition was unchanged be-
tween wild-type and PSD-95 mutant mice. Furthermore,and myristoyl-autocamtide 2-related inhibitory peptide
(myr-AIP, myr-KKALRRQEAVDAL, 1 nmole [19]), clearly topical application of a maximally effective concentra-
tion of NMDA (with glycine) or of ionomycin elicited thereversed the neuropathic thermal hyperalgesia and
mechanical allodynia seen in wild-type mice following same extent of CaM kinase II activation in naive PSD-
95 mutant mice as seen in wild-type littermates (TableCCI, whereas a control myristoylated peptide (myr-
GRRNAIHDE, 1 nmole) or saline vehicle were without 1). Thus, the spinal complement of CaM kinase II is
fully able to respond to Ca2-elevating stimuli in PSD-effect. Cell permeability of myr-AIP has been docu-
mented [19], and we have shown that it can effectively 95 mutant mice. Nevertheless, the NMDA receptor-
mediated Ca2 entry that occurs physiologically duringattenuate CaM kinase II autophosphorylation in spinal
cord following topical application (unpublished results). CCI appears to activate CaM kinase II more effectively in
wild-type than in PSD-95 mutant mice. PSD-95 thereforeAt 10–30 min following injection, the ipsilateral:contralat-
eral difference in PWL (thermal hyperalgesia) was signifi- seems to play an important role in facilitating the func-
tional coupling between the NMDA receptor and CaMcantly reduced to 18.2%  3.6%* and 21.2  2.3%* of
predrug control values by KN-93 and myr-AIP, respec- kinase II in CCI.
tively (n  6–9, *p  0.05 by Wilcoxon test), but not by
myr-control peptide (90.5%  8.6%) or saline (above). Molecular Mechanisms Disrupted
in PSD-95 Mutant MiceCorresponding values for the lateral difference in PWT
(mechanical allodynia) were 3.3%  1.4%, 37.3%  Changes either in protein phosphorylation or in pro-
tein:protein interactions might underlie the facilitated5.9%*, and 96.3%  5.8%. Recovery from the effects
of each reagent was largely complete by 60–80 min. NMDA receptor:CaM kinase II coupling in CCI. The
NMDA receptor is known to be phosphorylated by PKCThus, the NMDA receptor-dependent sensitization of
spinal neurons that is lacking in PSD-95 mutant mice and PKA at Ser896 and Ser897, respectively, within the
NR1 subunit [20], and PSD-95 is thought to bind thecrucially requires CaM kinase II to exert its functional
influence. PKA/PKC-docking protein AKAP79/150 [21] through do-
mains that are lacking in the mutant PSD-95 protein
here, suggesting that regulatory phosphorylation of theCaM Kinase II Activation in Response to Spinal
NMDA Receptor Stimulation or CCI NMDA receptor may be disturbed in the mutant mice.
Figure 3A shows that NR1-directed immunoprecipitatesWe directly monitored the activation state of spinal cord
CaM kinase II, isolated by immunoprecipitation from demonstrated a small increase in phospho-Ser897-NR1
immunoreactivity ipsilateral to CCI, which tended to betissue extracts. Following CCI, the proportion of CaM
kinase II activity that was constitutive (a read-out of less in PSD-95 mutant mice. No clear signal was ob-
tained for phospho-Ser896 immunoreactivity. Pan-NR1previous activation by Ca2/calmodulin) was signifi-
cantly greater in spinal cord ipsilateral to nerve injury control blots were also carried out to confirm that the
proportion of NR1 phosphorylated at Ser897 was in-compared to contralateral in wild-type animals, but not
in PSD-95 mutants (Table 1). This CCI-induced incre- creased (Figure 3A). Small reductions in the levels of
pan-NR1 immunoreactivity were seen ipsilateral to CCIment could be completely prevented by topical (R)-CPP,
confirming the requirement for NMDA receptors in medi- (in accordance with a previous report [22] and our un-
published data from the rat CCI model), and these reduc-ating the necessary Ca2 entry. The maximal activity of
CaM kinase II from spinal cord that could be evoked in tions were similar in PSD-95 mutant mice to those in
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Figure 3. Immunoblots for Phospho-Ser897-
NR1 and PKA-Related Proteins in NR1 and
NR2 Immunoprecipitates from Wild-Type and
PSD-95 Mutant Mice Either Following CCI
Surgery or in Naive Samples
(A) Western blot analysis of NR1 immunopre-
cipitates from spinal cord following sciatic
CCI carried out 12 days previously. Immuno-
precipitates from wild-type (wt) or PSD-95
mutant (open triangle) mice, ipsilateral or
contralateral to the injury, were probed for
phospho-Ser897-NR1 or pan-NR1 (n  5). The
mean ratio of phospho-Ser897-NR1:pan-NR1
immunoreactivity appeared to be increased
in wild-type ipsilateral samples, but not those
from the mutant mice. Approximate molecu-
lar weights are shown on the left.
(B) Western blot analysis of spinal cord pro-
teins captured by “pep6” NR2B C-terminal
(SIESDV) peptide-affinity resin [4]. Samples
derived from wild-type (wt) or PSD-95 mutant
(open triangle) mice were probed with anti-
bodies for NR1, PKA-RII	, PKA-RII, and
AKAP150 (n  8). There was no detectable
difference in the levels of any of these cap-
tured proteins when wild-type extracts were
compared to PSD-95 mutant extracts.
wild-type littermates. However, affinity capture of NMDA in wild-type mice (Figure 4B) where under the same
conditions in PSD-95 mutant mice, minimal levels ofreceptor complexes and associated proteins using an
NR2B tail peptide affinity resin [3, 4] showed consistently CaM kinase II	 (Figure 4A) or phospho-Thr286 CaM kinase
II	 (Figure 4B) were bound to NR2A/B subunits. Whenno changes in NR1, PKA-RII	, PKA-RII, or AKAP150
immunoreactivity between complexes from wild-type or blots were probed for control pull-down of NR2A and
NR2B subunits, uniform immunoreactivity was seen inPSD-95 mutant spinal cord (Figure 3B). This suggests
that altered AKAP-mediated kinase targeting to the wild-type and PSD-95 mutant tissue (Figure 4C). Simi-
larly, the tissue levels of CaM kinase II expression wereNMDA receptor complex in the PSD-95 mutant mice
does not underlie their neuropathic sensitization-resis- unaltered between wild-type and PSD-95 mutant mice
(Figure 4D). These data reveal a profound loss of NMDAtant phenotype.
To examine the coexistence of CaM kinase II and receptor-associated CaM kinase II	 and phospho-Thr286
CaM kinase II	 (an autonomously active form of theNMDA receptors in molecular complexes in the spinal
cord following CCI and to assess any difference caused enzyme) in the PSD-95 mutant mice. Disruption of this
interaction could provide a unified explanation of theby the mutant PSD-95 protein, we immunoprecipitated
NR2A/B subunits from spinal cord following CCI and linked dependence of sensitization on NMDA receptors
and CaM kinase II, together with the lack of CCI-inducedprobed for the levels of total and autophosphorylated
(activated) CaM kinase II	 immunoreactivity bound to behavioral reflex sensitization and CCI-induced CaM
kinase II activation seen in the PSD-95 mutants.the receptor. In wild-type spinal cord, we found high
levels of CaM kinase II	 associated with the receptor,
with an increase in CaM kinase II	 levels ipsilateral to Discussion
CCI compared to contralateral (Figure 4A). Similarly,
there was a marked increase in the levels of NR2A/B Using transgenic mice and a behavioral reflex model of
central sensitization following nerve injury [5, 6], we havebound phospho-Thr286 CaM kinase II	 ipsilateral to injury
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sion, to the termination of fine sensory afferents, and
matches a recent report of native PSD-95 immunoreac-
tivity in spinal cord [23]. In spinal cord of wild-type mice,
NR2 subunit immunoprecipitates additionally pulled
down both NR1 and PSD-95, confirming the presence
of spinal complexes of NMDA receptor subunits with
PSD-95.
The functional impact of the mutant PSD-95 construct
on neuropathic behavioral reflex sensitization was strik-
ing. Thermal hyperalgesia, mechanical allodynia, and
cold allodynia brought about by peripheral nerve injury
were all virtually absent in homozygous PSD-95 mutant
mice, despite the entirely undiminished nociceptive re-
flex behavior that they displayed following intraplantar
formalin. The enduring lack of neuropathic sensitization
seen in this phenotype is consistent with a brief report of
transient delays in the development of such sensitization
following a PSD-95 antisense reagent [23]. The current
report reveals for the first time that the requirement for
PSD-95 is both selective for neuropathic rather than
inflammatory sensitization and is absolute. Intrathecal
injection of NMDA receptor antagonist confirmed that
the neuropathic hyperalgesia and allodynia are depen-
dent on spinal NMDA receptors, matching other results
in neuropathic pain models [1]. Similar sensitivity to
NMDA receptor antagonist was seen for the late phase
inflammatory formalin response, as in other reports [11,
12]. Intrathecal injection of NMDA did not produce hy-
peralgesia and allodynia in PSD-95 mutant mice, at a
dose that was effective in naive wild-type mice. This is
consistent with a recent report of attenuated NMDA-
induced thermal hyperalgesia in the tail flick test when
animals were treated with a PSD-95 antisense reagent
[24]. The present data demonstrate that failure of a key
signal from spinal NMDA receptors in the PSD-95 mutant
mice is likely to underlie their inability to develop neuro-
pathic sensitization. Inflammatory sensitization, although
also requiring NMDA receptors, appears to be indepen-Figure 4. Immunoblots for CaM Kinase II	 Association with Spinal
dent of such PSD-95-mediated coupling of the NMDANR2A/B Immunoprecipitates
receptor to other proteins.(A) Western blot of NR2A/B immunoprecipitates from wild-type (wt)
and PSD-95 mutant (open triangle) spinal cord at the peak of behav- The sensitivity of NMDA receptor/PSD-95-dependent
ioral sensitization following CCI (n  8). Ipsilateral to injury (ipsi) neuropathic sensitization to CaM kinase II inhibitors
wild-type mice show increased levels of receptor bound CaM kinase suggests that this enzyme may play a key role down-
II when compared to the contralateral (contra) spinal cord. In com-
stream of the complex in producing the sensitized state.parison, the levels of receptor bound CaM kinase II in PSD-95 mutant
This idea is consistent with evidence that NMDA recep-spinal cord were greatly reduced both ipsilateral and contralateral
tor-mediated CaM kinase II translocation to synapsesto injury. Approximate molecular weights are shown on the left.
(B) Western blots probed for phospho-Thr286 CaM kinase II show and activation is important in long-term potentiation in
increased levels of NR-associated immunoreactivity ipsilateral to hippocampus [13, 25, 26], and spinal cord data showing
nerve injury in wild-type mice, but not PSD-95 (open triangle) mu- that CaM kinase II can elicit and mediate sensitization
tants. caused by the activator of nociceptive afferent fibers,(C) Recovery of NR2A and NR2B from the immunoprecipitates
capsaicin [27, 28]. Accordingly, we found that CCIshowed no detectable differences between wild-type and PSD-95
caused a partial activation of CaM kinase II in spinalmutant samples.
(D) Western blot of whole spinal cord lysate from naive wild-type cord. This was monitored by ex vivo enzyme assays, as
(wt) mice and PSD-95 mutant mice (open triangle) probed for CaM a constitutively active (autophosphorylated, previously
kinase II shows that the total content of CaM kinase II was similar activated) form of the enzyme. PSD-95 mutant mice
in wild-type and PSD-95 mutant mice. failed to show CCI-induced activation of CaM kinase II,
however, suggesting that PSD-95 is essential in assem-
addressed the role of the NMDA receptor-adaptor pro- bling an in vivo connection between the NMDA receptor
tein PSD-95 in neuropathic pain. Histochemical staining and CaM kinase II under these conditions. Total CaM
for the -galactosidase reporter incorporated into the kinase II activity and immunoreactivity were unaltered
mutant construct showed specific expression in many by CCI or by the PSD-95 mutation. The fact that a high
cells within lamina II of the superficial dorsal horn. This concentration of NMDA (plus glycine) could readily
evoke CaM kinase II activation in PSD-95 mutant ani-corresponds to regions of high NMDA receptor expres-
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